This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| DTU Technology Transfer | |
|---|---|
| Name | DTU Technology Transfer |
| Formation | 2006 |
| Headquarters | Kongens Lyngby, Denmark |
| Region served | Denmark; international |
| Parent organization | Technical University of Denmark |
DTU Technology Transfer
DTU Technology Transfer is the commercialization and innovation office affiliated with the Technical University of Denmark. It assists researchers and external partners with technology transfer, intellectual property management, licensing, and the creation of spin‑out companies. The office operates at the intersection of academic research, industrial collaboration, and public innovation policy, supporting translation of inventions from laboratories into marketable products and services.
DTU Technology Transfer sits within the ecosystem surrounding the Technical University of Denmark campus in Kongens Lyngby and interacts with institutions such as Copenhagen Business School, Aarhus University, University of Copenhagen, Novo Nordisk Foundation, and Innovation Fund Denmark. It engages with multinational corporations including Novo Nordisk A/S, Vestas Wind Systems A/S, Siemens A/S, A.P. Moller–Maersk, and Roche, as well as venture capital firms such as Nordic Eye Venture Capital, Sunstone Capital, and Seed Capital. The office navigates Danish legal frameworks including Danish Patent Act matters, collaborates with patent attorneys and firms like Hoffmann Eitle, and participates in European networks tied to European Patent Office, European Investment Fund, and EIT Health.
The office traces its mandate to broader trends in knowledge transfer exemplified by institutions such as Stanford University technology licensing initiatives, the Massachusetts Institute of Technology model, and national innovation strategies in Scandinavia. Its formative years followed policy shifts in Denmark during the early 2000s that emphasized commercialization and public‑private partnerships, engaging with actors like Danish Agency for Science and Higher Education and Danish Ministry of Higher Education and Science. Over time, it adopted practices from technology transfer offices at Imperial College London, ETH Zurich, and Karolinska Institutet, expanding capabilities in patenting, spin‑out formation, and industry consortia.
Governance aligns with the statutes of the Technical University of Denmark and oversight from university leadership including the DTU Board of Directors and the Rector office. Operational leadership has involved professionals recruited from law firms, corporate R&D organizations, and academic entrepreneurship units with backgrounds similar to executives from Novo Nordisk, Ramboll, and LEO Pharma. Advisory structures connect the office to external stakeholders including representatives from Vækstfonden and investment committees resembling those at Innovation Fund Denmark. Internal units coordinate with academic departments across DTU Department of Chemistry, DTU Electrical Engineering, DTU Compute, and DTU Mechanical Engineering.
Services include invention disclosure management, patent strategy, freedom‑to‑operate analysis, technology valuation, licensing negotiations, and entrepreneurship support. The office provides training and mentoring akin to programs at Entrepreneurship Centre Copenhagen and engages with incubators and accelerators such as Symbion, Founders House, and Copenhagen School of Entrepreneurship. It organizes matchmaking events linking researchers with corporate partners like Lundbeck, Grundfos, and Rockwool International and collaborates with funding bodies including Horizon Europe, NordForsk, and European Research Council for project follow‑on funding.
IP management follows protocols comparable to those at University of Cambridge and École Polytechnique Fédérale de Lausanne, coordinating patent prosecution with patent firms and managing licensing agreements for exclusive and non‑exclusive rights. Licensing negotiations engage technology scouts from firms such as Siemens, BASF, Schneider Electric, and Johnson & Johnson. The office balances academic publication timelines with patent filing, and structures agreements consistent with frameworks used by Wellcome Trust‑funded projects and Bill & Melinda Gates Foundation partnerships when applicable. It also administers material transfer agreements and confidentiality arrangements mirroring practices at Cold Spring Harbor Laboratory and Salk Institute.
DTU Technology Transfer supports formation of spin‑offs drawing inspiration from successful cases at institutions like Stanford and MIT. It helps founders with business plans, capitalization, board formation, and introductions to angel investors and VCs including ByFounders and Creandum. Startups emerging from DTU research have operated in sectors represented by firms like Novozymes, Coloplast, and ALK-Abelló; the office assists with seed funding, participation in accelerator programs such as Techstars and MassChallenge, and connections to corporate venture arms like Novo Seeds.
The office forges collaborative research agreements, consortium contracts, and long‑term strategic partnerships with corporates, SMEs, public research organisations, and hospitals including Rigshospitalet and Herlev Hospital. It engages in joint ventures, co‑development projects, and licensing alliances with players from the energy, biotech, medtech, and ICT sectors, echoing cooperation models used by Shell Technology Ventures, GlaxoSmithKline, and ABB. International outreach includes participation in networks like European Institute of Innovation and Technology and bilateral ties with universities such as Technical University of Munich and Chalmers University of Technology.
Impact assessment uses indicators such as number of invention disclosures, patents filed, licenses executed, spin‑offs created, and jobs generated, comparable to metrics reported by Association of University Technology Managers and AUTM. Economic influence is evaluated through follow‑on funding amounts from sources like Horizon 2020 and private investment rounds, contribution to regional clusters in Greater Copenhagen, and partnerships with industrial leaders such as Vestas and Maersk. Social and scientific impact is tracked via collaborations with hospitals and research institutes, citation patterns aligned with Clarivate Analytics metrics, and technology adoption in sectors represented by Novo Nordisk and Grundfos.
Category:Technology transfer offices